Na nɔmal tin fɔ fil smɔl frayd ɛn wɔri we yu kam fɔ no se yu gɛt dayabitis. Bɔt di bɛst tin na dat, bɛtɛ tritmɛnt dɛn de tide pas aw i bin de bifo fɔ ɛp yu fɔ kɔntrol yu dayabitis ɛn liv fayn layf. Yu ɛn yu dɔktɔ go mek wan plan fɔ ɛp yu fɔ kɔntrol di glukɔs we de na yu blɔd ɛn fɔ mek yu gɛt wɛlbɔdi.
Sɔntɛnde, wan mɛrɛsin nɔ go du fɔ mek yu blɔd shuga nɔmal. If na so i bi, yu dɔktɔ kin ad ɔda mɛrɛsin dɛn. Lɛ wi tɔk bɔt dɛn tritmɛnt ya wan bay wan.
Medikeshɔn dɛn we dɛn kin yuz fɔ it
Bɔrku pipul dɛm wae gɛt Tayp 2 Dayabitis kin bigin fɔ trit dɛn wit wan mɛrɛsin wae dɛn kɔl Metformin. Dis kin wok mɔ bay we i de ridyus di shuga we yu liva de mek. Metformin de ɛp yu mɔsul dɛn bak fɔ tek di ɔmon insulin bɛtɛ, we de ɛp yu bɔdi fɔ yuz di shuga we i de gɛt.
Dɛn kin tek dis mɛrɛsin tu tɛm insay di de. Di tin we impɔtant pas ɔl na fɔ tek dis pil wit it. Dis kin rili ridyus di sayd ɛfɛkt dɛm lɛk we yu bɛlɛ at pwɛl, mɔ we yu gɛt dayarɛa.
If di metformin nɔmɔ nɔ de kɔntrol di shuga we yu gɛt na yu blɔd, yu dɔktɔ kin ad yu doz ɔ ad nyu kayn mɛrɛsin. Lɛ wi tek wan luk pan wetin na dɛn ɔda mɛrɛsin ya.
Mɛmba se, yu fɔ jɔs yuz ɔl dɛn mɛrɛsin ya ɔnda di advays we yu dɔktɔ gi yu. Yu nɔ fɔ jɔs tek dɛn jɔs bikɔs yu padi de yuz dɛn, bikɔs ɔlman in bɔdi difrɛn.
| Tayp fɔ mɛrɛsin ɛn simpul ɛksplen | Ɛgzampul dɛn (brand nem dɛn) . |
|---|---|
| Alfa-glukosidayz inhibitɔ dɛn Dɛn tin ya kin wok bay we dɛn kin mek di bɔdi nɔ brok di it dɛn we gɛt stach we wi kin it, lɛk bred ɛn pɔt, ɛn dis kin mek di shuga we de na di blɔd nɔ bɔku wantɛm wantɛm. | Akabɔs (Prɛkɔs), Miglitɔl (Glayset) . |
| Bayl asid sikwεstrant dεm Dis na rili mεdikeshכn dεm we de lכs bad kכlestכl (LDL kכlestכl) na di bכdi. Bɔt dɛn dɔn si bak se dɛn kin mek di blɔd shuga go dɔŋ. Dis kin bi sef fɔ pipul dɛm wae nɔr kin ebul fɔ tek ɔda mɛrɛsin wae gɛt dis sik bikɔs ɔf liva sik. | Kolsevelam (Wɛlkɔl) ɛn . |
| DPP-4 inhibito dεm Dɛn tin ya kin ɛp fɔ kɔntrol dayabitis bay we dɛn de ridyus di blɔd shuga. | Alogliptin (Nɛsina), Linagliptin (Tradjenta), Saksagliptin (Onglyza), Sitagliptin (Januvia) |
| GLP-1 rεsεptכr agonist dεm Dɛn tin ya kin tɛl di bɔdi fɔ mek mɔ insulin. Dɛn kin mek bak di rit we yu de digest slo ɛn mek yu fil ful. Sɔm pan dɛn tin ya de bak as injɛkshɔn. | Dulaglutayd (Trulisiti), Ɛksɛnayt (Byetta), Liraglutayd (Victoza), Sɛmaglutayd (Ozempic, Rybelsus) |
| GIP ɛn GLP-1 rεsεptכr agonist Dis na nyu kayn mɛrɛsin. Dɛn tin ya kin ɛp fɔ mek insulin bɔku nɔmɔ we di shuga na di blɔd bɔku. | Tirzepatide (Mɔnjaro) we dɛn kɔl . |
| Meglitinid dɛn we dɛn kɔl Dɛn tin ya kin ɛp di bɔdi fɔ mek mɔ insulin. Dɛn kin tek dɛn mɛrɛsin ya bifo dɛn it di men tin dɛn. | Nateglinayd (Starliks), Rɛpaglinid (Prandin) . |
| SGLT2 inhibito dεm Dis kayn mɛrɛsin rili spɛshal. I de wok bay we i de pul di shuga we pasmak na yu blɔd tru yu kidni ɛn urine. Sɔm mɛrɛsin (lɛk Empagliflozin) kin ɛp bak fɔ ridyus di risk fɔ gɛt at atak pan pipul dɛm wae gɛt hat sik. | Kanagliflɔzin (Invokana), Dapagliflɔzin (Farxiga), Ɛmpagliflɔzin (Jardiance) |
| Sɔlfɔnilɔria dɛn Dɛn tin ya kin mek yu pankrias mek mɔ insulin. | Glimepirayd (Amaryl), Glipizayd (Glukotrol), Glayburayd (Dayabeta) . |
| Tiazolidindiɔn (TZD) dɛn . wetin dεn ya de du na fכ mek di mכsul εn fεt tisu dεm de rεspכnd to insulin mכr. Dat min se dɛn kin mek insulin wok fayn mɔ ɛn mɔ. | Piɔglitazɔn (Aktos), Rosiglitazɔn (Avandia) . |
Insulin tritmɛnt
Insulin na impɔtant ɔmon we wi yon bɔdi de mek we de ɛp fɔ mek di shuga we de na di blɔd go insay di sɛl dɛn fɔ yuz am fɔ gɛt ɛnaji.
Naw, if yu fɔ tek insulin injɛkshɔn, nɔ ɛva tink se, "O, a go lɔs kɔntrol pan mi sik." Dat nɔto so i bi. Ɔlman in bɔdi difrɛn. Sɔntɛm if yu dɔn gɛt dayabitis fɔ lɔng tɛm, if yu blɔd shuga rili bɔku, ɔ if yu gɛt ɔda wɛlbɔdi prɔblɛm dɛn we de mek i nɔ izi fɔ kɔntrol yu blɔd shuga wit pils nɔmɔ, yu dɔktɔ go tɛl yu fɔ yuz insulin wit pils.
Bɔku pipul dɛn kin injekt insulin insay di fat layt we de ɔnda di skin. Yu dɔktɔ go disayd ɔmɔs yu nid fɔ wan de.
Difrɛn kayn insulin dɛn de bak.
- Dɛn kin du am kwik kwik wan: Dɛn tin ya kin wok insay sɔm minit afta dɛn dɔn injɛkt am ɛn dɛn kin de fɔ sɔm awa.
- Short-acting: I de tek effekt insay haf awa ɛn i de las fɔ 3-6 awa.
- intamεdiεt-aktin: I de tek εfεkt insay 2-4 awa εn i de las 12-18 awa.
- I kin wok fɔ lɔng tɛm: Dɛn tin ya kin ɛp fɔ mek di blɔd shuga nɔ chenj ɔl di de.
Yu kin gɛt insulin wit sirinj, pen we dɛn dɔn ful-ɔp, ɔ smɔl tin we dɛn put ɔnda di skin (insulin pɔmp). Yu dɔktɔ go tɛl yu di rayt we fɔ du dis.
Aw fɔ yuz di mɛrɛsin kɔrɛkt wan?
Dis na di pat we impɔtant pas ɔl.
- Fɔ fala yu dɔktɔ in instrɔkshɔn: Tek yu mɛrɛsin jɔs lɛk aw yu dɔktɔ tɛl yu, di tɛm ɛn di mɔnt we dɛn tɛl yu. Sɔm mɛrɛsin dɛn fɔ tek wit it fɔ ridyus di sayd ɛfɛkt dɛn. Mek shɔ se yu fala dɛn instrɔkshɔn dɛn de.
- Fɔ kip yu mɛrɛsin: Yu dɔktɔ ɔ fama go advays yu bɔt aw fɔ kip yu mɛrɛsin. Ɛspɛshali tin dɛn lɛk insulin nid fɔ de na di rayt tɛmpracha. Dis go ɛp fɔ kip di kwaliti fɔ di mɛrɛsin.
- Tek tɛm wit rɔm:I nɔ fayn fɔ drink rɔm we yu de tek sɔm mɛrɛsin dɛn lɛk mɛtfɔmin. Pipul wae gɛt shuga kin fil bad bɔt aw rɔm kin fil pas ɔda pipul dɛm. So tek tɛm bad bad wan if yu de drink rɔm. I bɛtɛ fɔ tɔk to yu dɔktɔ bɔt am.
Mɛsej we dɛn kin kɛr go na os
- Dayabitis na sik wae yu kin ebul fɔ kɔntrol, so nɔr frayd am tumɔs.
- Wok wit yu dɔktɔ fɔ mek di bɛst tritmɛnt plan fɔ yu. Nɔ fred fɔ aks kwɛstyɔn if yu gɛt ɛni wan.
- Bɔku pipul dɛn kin bigin fɔ trit dɛn wit wan pil we dɛn kɔl mɛtfɔmin. If yu tek am wit it, i kin ridyus di bad tin dɛn we kin apin to yu.
- If yu gɛt fɔ yuz insulin, dat nɔ min se yu nɔ ebul fɔ kɔntrol yu sik. Na tritmɛnt we nid ɛn we rili wok.
- I rili impɔtant fɔ tek di mɛrɛsin we di dɔktɔ tɛl yu fɔ tek, di rayt tɛm, di rayt doz, ɛn jɔs lɛk aw dɛn tɛl yu fɔ tek.
💬 Comments (0)
No kɔmɛnt nɔ de yet. Ad yu kɔmɛnt ya fɔ di fɔs tɛm.
Ad yu kɔmɛnt